These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517 [TBL] [Abstract][Full Text] [Related]
4. SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. Kumar G; Banerjee T; Kapoor N; Surolia N; Surolia A IUBMB Life; 2010 Mar; 62(3):204-13. PubMed ID: 20131353 [TBL] [Abstract][Full Text] [Related]
5. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase. Frecer V; Megnassan E; Miertus S Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192 [TBL] [Abstract][Full Text] [Related]
6. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches. Neves BJ; Bueno RV; Braga RC; Andrade CH Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives. Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway. Lu H; Tonge PJ Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820 [TBL] [Abstract][Full Text] [Related]
13. Methylenebissantin: a rare methylene-bridged bisflavonoid from Dodonaea viscosa which inhibits Plasmodium falciparum enoyl-ACP reductase. Muhammad A; Anis I; Ali Z; Awadelkarim S; Khan A; Khalid A; Shah MR; Galal M; Khan IA; Iqbal Choudhary M Bioorg Med Chem Lett; 2012 Jan; 22(1):610-2. PubMed ID: 22082562 [TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors. Shah P; Siddiqi MI SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586 [TBL] [Abstract][Full Text] [Related]
15. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase. Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979 [TBL] [Abstract][Full Text] [Related]
16. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083 [TBL] [Abstract][Full Text] [Related]
17. Combined 3D-QSAR and Molecular Docking Study for Identification of Diverse Natural Products as Potent Pf ENR Inhibitors. Wadhwa P; Saha D; Sharma A Curr Comput Aided Drug Des; 2015; 11(3):245-57. PubMed ID: 26517356 [TBL] [Abstract][Full Text] [Related]
18. Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents. Schrader FC; Glinca S; Sattler JM; Dahse HM; Afanador GA; Prigge ST; Lanzer M; Mueller AK; Klebe G; Schlitzer M ChemMedChem; 2013 Mar; 8(3):442-61. PubMed ID: 23341167 [TBL] [Abstract][Full Text] [Related]
19. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli. Chhibber M; Kumar G; Parasuraman P; Ramya TN; Surolia N; Surolia A Bioorg Med Chem; 2006 Dec; 14(23):8086-98. PubMed ID: 16893651 [TBL] [Abstract][Full Text] [Related]